Dr. Lorraine Lipscombe has developed a successful research program that focuses on the prevention, care and outcomes of diabetes, with a specific focus on diabetes in women. Her team is currently piloting a home-based lifestyle intervention program for women with recent gestational diabetes, to lower their future risk of type 2 diabetes. In addition, Dr. Lipscombe is leading a research program addressing the complex relationship between type 2 diabetes and cancer. Her studies of population-based health administrative data have shown that diabetic women get fewer screening mammograms, and that postmenopausal breast cancer survivors have a higher incidence of diabetes. She is now studying other factors that increase breast cancer risk in diabetic women. Another key area of interest focuses on the improvement of health service delivery for diabetes management. Dr. Lipscombe has shown that low-income patients with diabetes have higher mortality rates, and thus must be the focus of greater preventive efforts.
Dr. Lipscombe has published over 80 peer-reviewed papers. Her research program has been supported by the Lawson Foundation, the Canadian Diabetes Association, and the Canadian Institutes for Health Research.
MSc, Clinical Epidemiology, Health Policy, Management and Evaluation, University of Toronto, 2005
MD, McGill University, 1998
Health System Solutions